Abstract

ObjectivesThe aim was (i) to evaluate the accuracy of equilibrium-phase high spatial resolution (EP) contrast-enhanced magnetic resonance angiography (CE-MRA) at 1.5T using a blood pool contrast agent for the preoperative evaluation of deep inferior epigastric artery perforator branches (DIEP), and (ii) to compare image quality with conventional first-pass CE-MRA.MethodsTwenty-three consecutive patients were included. All patients underwent preoperative CE-MRA to determine quality and location of DIEP. First-pass imaging after a single bolus injection of 10 mL gadofosveset trisodium was followed by EP imaging. MRA data were compared to intra-operative findings, which served as the reference standard.ResultsThere was 100% agreement between EP CE-MRA and surgical findings in identifying the single best perforator branch. All EP acquisitions were of diagnostic quality, whereas in 10 patients the quality of the first-pass acquisition was qualified as non-diagnostic. Both signal- and contrast-to-noise ratios were significantly higher for EP imaging in comparison with first-pass acquisitions (p<0.01).ConclusionsEP CE-MRA of DIEP in the preoperative evaluation of patients undergoing a breast reconstruction procedure is highly accurate in identifying the single best perforator branch at 1.5Tesla (T). Besides accuracy, image quality of EP imaging proved superior to conventional first-pass CE-MRA.

Highlights

  • The number of mastectomies in breast cancer is increasing, and so is the number of patients that opt for reconstructive breast surgery after mastectomy [1,2,3]

  • Several authors have demonstrated that MR angiography can be used in preoperative imaging of the perforator branches of the deep inferior epigastric artery (DIEA) [5,6,8,15,16]

  • Considering the small size of DIEA perforator branches we wondered whether it was possible to obtain high spatial resolution equilibrium-phase (EP) images with improved resolution compared to first-pass acquisitions using a recently described new intravascular contrast agent, gadofosveset trisodium [17,18]

Read more

Summary

Introduction

The number of (prophylactic) mastectomies in (the prevention of) breast cancer is increasing, and so is the number of patients that opt for reconstructive breast surgery after mastectomy [1,2,3]. Disadvantages of the DIEP procedure, on the other hand, include difficulties in harvesting the flap, resulting in considerably longer dissection times, and the fact that long-term results depend heavily on the quality of the perforator branch supplying the flap. Several studies have been performed using state-of-the-art 3T hardware, instead of the more widely available 1.5T magnetic resonance angiography (MRI) systems [5,6,8,15,16], and most of these studies have employed conventional extracellular contrast agents in combination with first-pass imaging to visualize DIEA perforator branches. Considering the small size of DIEA perforator branches we wondered whether it was possible to obtain high spatial resolution equilibrium-phase (EP) images with improved resolution compared to first-pass acquisitions using a recently described new intravascular contrast agent, gadofosveset trisodium [17,18]. Blood pool agents have important benefits over conventional small-sized extracellular agents in CE-MRA, such as the lengthened imaging window and the relatively large R1 [19], both allowing longer acquisition times, enabling data acquisition at a very high resolution and with very high accuracy

Objectives
Methods
Results
Conclusion

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.